The Silver Award and Lecture honours individuals who have made significant contributions in the field of paediatric HIV and AIDS. Herman and Gertrude Silver endowed the lecture fund as a lasting memorial to their children, who were treated at Children’s Hospital. Since the first Silver Lecture in 1990, the Fund has recognized physicians and researchers from leading academic institutions.
J. Brooks Jackson, M.D., MBA is the Baxley Professor and director of Pathology at Johns Hopkins University School of Medicine, where he also is pathologist-in-chief. Dr. Jackson serves on the executive board of MU-JHU Care in Kampala, Uganda, a joint program of Johns Hopkins University and two Ugandan institutions, Makerere University and Mulago Hospital.
He has helped lead medical efforts against HIV in Uganda for nearly 20 years, with a special focus on preventing and treating HIV infection in children born to HIV-infected mothers. In 1999, he reported major public health advances in preventing mother-to-child HIV transmission in a landmark clinical study using the drug neveripine.
In his Silver Lecture, Dr. Jackson summarized worldwide trends in preventing perinatal HIV transmission. Antiviral drugs have achieved “tremendous success” in combating pediatric HIV in developed countries, but only moderate success in developing countries, because of economic and social constraints. He continues to collaborate with other researchers and public health experts in seeking more effective treatment regimens for millions of children and parents in the developing world.
MEDICA.de; Source: Children's Hospital of Philadelphia